Kenvue named Franchise Pick at Jefferies

Jefferies analyst Keith Devas is naming Kenvue to the firm’s Franchise Picks list that screens for differentiated analysis, supported by catalysts, and sit at valuation levels that suggest upside. As a result of becoming a standalone company, recognizable consumer health brands in solid categories are getting “needed reinvestment dollars”, and the firm sees a business that swings to mid-single-digit organic growth and double-digit EPS growth in FY26, with ample capacity for capital returns, the analyst tells investors in a research note. Jefferies also rates at Kenvue at Buy with $27 price target